CSIMarket
 
Akero Therapeutics Inc   (AKRO)
 

The company added some great surprise for the stock market, presenting a relevant rise in most recent fiscal period with operating deficit of $-25.42 millions

Akero Therapeutics Inc reported fourth quarter of 2022 operating deficit of $-25.42 millions


Published Mar 18 2023
Goran Soko / CSIMarket.com Contributer


pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons As the earnings cycle of fiscal October to December 31 2022 resumes, many entities have declared their earnings. Some of them, are multiple constituents of the Major Pharmaceutical Preparations industry. And today, AKRO reported operating deficit of $-25.42 millions, for the financial fourth quarter of 2022.

This could be clearly marked as promising revelation, in absence of more convalescent comparisons. The improvement from the operating deficit compared to the comparable period a year before of $-32.439 millions. This also administers many analysts optimism about AKRO.


There was also some relief on the net loss. as the deficit has been cut from the period, a year before. This was a main verdict in the fourth quarter of 2022. Deficit was $-23.059 millions, while in the fourth quarter of 2021 $-32.424 millions.

Additionally, the company claimed as well net deficit of $-112.03 millions and for the financial period 2022, Revenues of $0.00 millions.

Major Pharmaceutical Preparations The company has decreased it's loss per share to $-2.87 from $-2.89 in the prior fiscal year, while by 0 % from $0.00 millions a year before.

Akero Therapeutics Inc is expected to report next financial recent numbers on May 05, 2023.



Akero Therapeutics Inc's Effective Tax Rate

Akero Therapeutics Inc's Revenue Growth





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071